Navigation Links
Laut einer Studie setzen sich die großen Pharmaunternehmen mehr für den Zugang zu Medizin in Entwicklungsländern ein als noch vor zwei Jahren
Date:11/27/2012

AMSTERDAM, November 28, 2012 /PRNewswire/ --

Der jüngste "Access to Medicine Index", der die führenden 20 Pharmaunternehmen nach ihren Bemühungen beurteilt, ihre Medikamente in Entwicklungsländern besser zugänglich zu machen, stellte fest, dass die Branche in diesem Punkt besser abschneidet als noch vor zwei Jahren. GlaxoSmithKline übertrifft dabei weiterhin die anderen Unternehmen, doch immer mehr führende Pharmaunternehmen schließen auf.

     (Photo: http://photos.prnewswire.com/prnh/20121128/579726 )

Der am Mittwoch veröffentlichte Index führt Johnson & Johnson als einen der stärksten Aufsteiger an; das Unternehmen konnte sich von der 9. Position und dem Mittelfeld im Index des Jahres 2010 in diesem Jahr auf den 2. Rang nur knapp hinter GlaxoSmithKline hocharbeiten. Das Unternehmen ist dabei einer der beiden Newcomer in den Top 3. Der Aufstieg ist im Wesentlichen der Konsolidierung seiner Aktivitäten in Hinblick auf die Verbesserung des Medikamentenzugangs unter einer einzigen Geschäftseinheit, was eine strategischere und stärker integrierte Vorgehensweise ermöglicht hat, sowie der Akquisition des Impfstoffherstellers Crucell zu verdanken, wodurch die Relevanz der Investitionen in Forschung und Entwicklung verbessert wurde. Zudem hat das Unternehmen auch insgesamt mehr über die Aktivitäten zur Verbesserung des Medikamentenzugangs bekannt gegeben.

"Der diesjährige Index zeigt, dass die Unternehmen bei ihren Bemühungen zur Verbesserung des Zugangs zu medizinischer Versorgung intern besser organisiert sind und jene, denen dies am besten gelingt, tendenziell auch in den anderen von uns erfassten Bereichen besser abschneiden. Die führenden Unternehmen legen die Latte immer höher", erklärte Wim Leereveld, Gründer und CEO des Access t
'/>"/>

SOURCE Access to Medicine Foundation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Lance Armstrong Update: Arrogant Even After Conceding Doping Charges, Asserts Former White House & WADA Spokesman Robert Weiner; Victory for Clean Sport but "Dark Message" Is Science Must Catch Up to Masking Agents Allowing Cheating
2. Desitin Pharmaceuticals entscheidet sich für das cloudbasierte Veeva CRM zur Unterstützung seiner Expansion auf den britischen Markt
3. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
4. First assessment of individual RLS domains in new post-hoc analyses of Neupro® studies
5. Southern Research Signs Agreement with Apath, LLC to Conduct Preclinical Studies with Virus-Based HCV Screenings
6. Unigenes Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies
7. Agendia Announces Nine Studies in Breast and Colon Cancer for Presentation at 2012 Annual Meeting of the American Society of Clinical Oncology (ASCO)
8. Lilly and Boehringer Ingelheim Present Data at the 72nd American Diabetes Association Scientific Sessions® from Phase II Studies Comparing Investigational Novel Basal Insulin to Insulin Glargine
9. Abbott Presents Results of Clinical Studies Evaluating Its Investigational Treatment for Advanced Parkinsons Disease
10. Lexicon Announces Publication of Results of Two Studies of LX4211 in Patients with Type 2 Diabetes in the Journal Clinical Pharmacology & Therapeutics
11. Pulse Oximetry Screening Hailed as the New Milestone to Combat Critical Congenital Heart Disease - Signal Extraction Technology Leading the Way in Large, Independent Clinical Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... BOSTON , January 23, 2015 Heptares ... is delighted to announce that the Malcolm Campbell ... Congreve (Vice President of Chemistry), Fiona Marshall ... (Chief Executive Officer and co-founder) for the seminal contributions to ...
(Date:1/22/2015)... is pleased to announce the appointment of Dr. ... Biochemistry. Scott joins the company after previous scientific leadership positions ... course of his nearly 20 year career in therapeutics ... recognized thought leader in the biosensor field and particularly ...
(Date:1/22/2015)... , Jan. 22, 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ... focus on Omega-3 therapies for cardiovascular disease and overall health ... Company,s accomplishments in 2014 and its outlook for 2015 from ... Fellow Shareholders, We would like to take this ...
Breaking Medicine Technology:Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 2Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 4BiOptix Expands Leadership Team with the Appointment of Dr. Scott Klakamp as Vice President of Chemistry and Biochemistry 2Pivotal Therapeutics: Year in Review and CEO Update 2Pivotal Therapeutics: Year in Review and CEO Update 3Pivotal Therapeutics: Year in Review and CEO Update 4Pivotal Therapeutics: Year in Review and CEO Update 5Pivotal Therapeutics: Year in Review and CEO Update 6Pivotal Therapeutics: Year in Review and CEO Update 7
... OrbusNeich announced that data from multiple clinical trials supporting ... cases where prolonged dual antiplatelet therapy (DAPT) is not ... "How to assess and treat patients who are not ... 2011 in Paris. Presenters discussed current treatment ...
... LAKE CITY, May 19, 2011 Paradigm Medical Industries, ... notification from its Italian partner, Costruzione Strumenti Oftalmici (CSO), ... pages and 24 attachments to the U.S. Food and ... for the Paramax™. This supportive information was submitted to ...
Cached Medicine Technology:OrbusNeich's Genous™ Stent is Safe and Effective in Cases Where Prolonged Dual Antiplatelet Therapy is Not Advisable as Presented at EuroPCR 2011 2OrbusNeich's Genous™ Stent is Safe and Effective in Cases Where Prolonged Dual Antiplatelet Therapy is Not Advisable as Presented at EuroPCR 2011 3OrbusNeich's Genous™ Stent is Safe and Effective in Cases Where Prolonged Dual Antiplatelet Therapy is Not Advisable as Presented at EuroPCR 2011 4Paramax™ Moves Closer To FDA Approval 2
(Date:1/22/2015)... Dallas, TX (PRWEB) January 22, 2015 ... the issue of experience and person-centeredness in the long-term ... moving towards action across the continuum. The paper, “The ... the Continuum,” engages perspectives and practices of the patient, ...
(Date:1/22/2015)... For over 20 years, Dr. David Cruz of Cruz Chiropractic ... treated just about every type of injury that can result from ... same twenty-plus years, the team at Doctors on Liens ... possible doctor. With the combined breadth of experience between ...
(Date:1/22/2015)... 2015 A study recently published ... journal Medicine & Science in Sports & Exercise ... help reduce gastrointestinal (GI) problems associated with physical ... in the double-blind, placebo-controlled study took 10 grams ...
(Date:1/22/2015)... January 22, 2015 IsoComforter, Inc. has introduced ... with patented IsoTube design to treat specific body parts and ... most progressive and easy to use patented cold therapy machine ... sports related orthopedic and muscle injuries. IsoComforter has become ...
(Date:1/22/2015)... Mass. (PRWEB) January 22, 2015 EBSCO ... (AMA) are expanding their relationship in an effort to ... around the world. While EBSCO has long made AMA journals ... a sales agent for The JAMA Network. , ...
Breaking Medicine News(10 mins):Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4
... Records Into a User,s New ... Google Health Profile, ... delivers a variety of integrated healthcare services,announced today that it is ... that launched yesterday which allows users to,store, organize, and manage their ...
... Healthcare Provider vertical will be first to obtain certification ... for GE Centricity Enterprise software, ... SAY ), a leading global consulting and information,technology services ... customers deploying healthcare IT,solutions based on GE Centricity Enterprise software., ...
... to have operation before emergency procedure is needed , , TUESDAY, ... than white men to have elective surgery to repair abdominal ... data on men 65 and older who had elective or ... conclusion. , An abdominal aortic aneurysm occurs when there,s a ...
... PRINCETON JUNCTION, N.J., May 20 Lutronic, one ... laser systems,announced today that it has received FDA ... wavelength system. This dual pulse Q-Switched Nd:,Yag laser ... II. It is,specifically designed to treat a wide ...
... designing a preventive HIV vaccine, the National Institute of ... Institutes of Health, is launching a new program to ... can produce antibodies with the capacity to neutralize HIV. ... the scientific foundation of HIV vaccine research through a ...
... Recognition Highlights Organization,s Commitment to Environmental Health, ... Permanente received the,"System for Change" award for ... Excellence Summit in Pittsburgh., The award, ... to gather,environmental data, set goals, and encourage ...
Cached Medicine News:Health News:UNIVAL, Inc. Becomes a Google Health(TM) Integrated Service 2Health News:GE and Satyam Announce Global Alliance to Provide Healthcare IT Services 2Health News:GE and Satyam Announce Global Alliance to Provide Healthcare IT Services 3Health News:GE and Satyam Announce Global Alliance to Provide Healthcare IT Services 4Health News:Black Men Less Likely to Choose Elective Stomach Aorta Surgery 2Health News:Lutronic Inc. Announces FDA Clearance of Its Spectra VRM III Q-Switched Nd: Yag Laser System for Treating a Broad Spectrum of Dermatological and Aesthetic Conditions 2Health News:Lutronic Inc. Announces FDA Clearance of Its Spectra VRM III Q-Switched Nd: Yag Laser System for Treating a Broad Spectrum of Dermatological and Aesthetic Conditions 3Health News:NIAID to advance B-cell approach to HIV vaccines 2Health News:NIAID to advance B-cell approach to HIV vaccines 3Health News:Kaiser Permanente Wins National Green Awards 2Health News:Kaiser Permanente Wins National Green Awards 3
CleanBox DNA workstation with two 254nm UV lambs & 12-hr timer, 90cm (36-inch)width, single door, 115V (w/crating)...
... highthroughput reading of tube racks. Its camera-based vision ... one second per rack, making it ideal for ... the reader allows a rack to be read ... arms. An optical safety switch prevents a rack ...
... Polypropylene workbench top with powder-coated ... from 25"-34". Available in hundreds ... include shelves, drawers, light fixtures ... an expert in custom building ...
Perforated or Rod Top, Free Standing or Wall Mounted, Storage Cubby Optional, Polypropylene Construction...
Medicine Products: